HRPC(SH:600829)2018-04-11 16:00Financial Performance - Operating revenue for the period was CNY 1,706,007,492.92, representing a decline of 17.89% year-on-year[7] - Net profit attributable to shareholders was CNY 69,501,189.49, an increase of 5.22% compared to the same period last year[7] - The company reported a net profit excluding non-recurring gains and losses of CNY 69,335,119.41, up 7.31% year-on-year[7] - Total operating revenue for Q1 2018 was CNY 1,706,007,492.92, a decrease of 17.9% compared to CNY 2,077,798,866.20 in the same period last year[22] - Total operating costs for Q1 2018 were CNY 1,611,579,295.92, down 19.0% from CNY 1,989,958,793.89 in Q1 2017[22] - Net profit for Q1 2018 reached CNY 69,501,179.58, an increase of 5.5% from CNY 66,055,291.39 in Q1 2017[23] - Total profit for Q1 2018 was CNY 94,649,623.77, an increase of 5.5% compared to CNY 89,762,878.71 in Q1 2017[23] - Earnings per share for Q1 2018 were CNY 0.1199, compared to CNY 0.1139 in the previous year, reflecting a growth of 5.3%[24] Cash Flow - Net cash flow from operating activities increased by 111.55% to CNY 184,685,250.44[7] - The net cash flow from operating activities for the first quarter of 2018 was ¥184,685,250.44, an increase from ¥87,299,929.22 in the previous year, representing a growth of approximately 111.7%[30] - Cash received from sales of goods and services in Q1 2018 was CNY 1,889,301,024.80, a decline of 6.5% from CNY 2,020,706,561.39 in Q1 2017[29] - The cash inflow from operating activities totaled ¥1,930,258,725.90, while cash outflow was ¥1,745,573,475.46, leading to a positive cash flow from operations[30] - The cash outflow for purchasing goods and services was ¥1,534,625,135.09, down from ¥1,723,624,684.02 in the previous year[30] - The cash inflow from investment activities was primarily driven by cash received from the recovery of investments amounting to ¥270,000,000.00[32] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,785,280,264.89, a decrease of 1.16% compared to the end of the previous year[7] - The company's current assets totaled ¥4,270,855,972.42, down from ¥4,317,503,183.59, indicating a decrease of about 1.08%[16] - Total liabilities decreased to ¥3,103,750,691.20 from ¥3,229,369,249.72, reflecting a decline of about 3.9%[18] - The company's equity attributable to shareholders increased to ¥1,681,529,426.49 from ¥1,612,028,237.00, marking an increase of approximately 4.3%[18] - The total current liabilities decreased to ¥2,953,778,793.24 from ¥3,077,947,462.89, indicating a decline of about 4.0%[17] Financial Expenses - The company reported a significant increase in financial expenses, rising by 359.75% to CNY 7,926,888.14 due to increased discount interest[10] - Financial expenses increased significantly to CNY 7,926,888.14 in Q1 2018 from CNY 1,724,175.46 in Q1 2017, marking a rise of 359.5%[23] Shareholder Information - The number of shareholders at the end of the reporting period was 20,304, with the largest shareholder, Harbin Pharmaceutical Group, holding 74.82%[9] Corporate Changes - The company is undergoing a change in actual control from Harbin State-owned Assets Supervision and Administration Commission to CITIC Capital Holdings[10] - The company has terminated a major asset restructuring plan involving the purchase of GNC equity, with the transaction subject to changes in the implementation entity[11]